Business Standard

Lyka Labs hits 5% upper circuit after Ipca buys 1 mn shares via bulk deals

On Monday, Ipca Laboratories purchased 1.05 million equity shares representing 3.65 per cent stake in Lyka Labs at price of Rs 123 per share on the BSE via bulk deals

Lyka Labs
Premium

Lyka Labs

SI Reporter Mumbai
Shares of Lyka Labs were locked at the upper circuit for the second straight day, up 5 per cent at Rs 129.15, also its 52-week high on the BSE on Tuesday, after Ipca Laboratories bought 1 million shares of pharmaceuticals company via open market deals.

On Monday, November 23, 2021, Ipca Laboratories purchased 1.05 million equity shares representing 3.65 per cent stake in Lyka Labs at price of Rs 123 per share on the BSE via bulk deals, the exchange data reveals.

Vipul Priyakant Dalal (240,121 shares) and Shreyans Jashwantlal Shah (345,000 shares) have sold the company’s shares

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Nov 23 2021 | 12:12 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com